(Total Views: 361)
Posted On: 08/17/2020 12:02:26 AM
Post# of 208
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
TSOI is the only biotech company that is currently offering multiple FOUR pathways for treatment of covid-19 which is mind boggling considering TSOI is only less than 15 million market cap. :
1) prevention with QuadraMune (500 volunteer trial for prevention and protection) ,
https://www.prnewswire.com/news-releases/ther...71981.html
2) QM and Metformin used together :It was discovered that the ability of QuadraMune™ to protect the lungs from inflammation that resembles coronavirus-induced pathology is markedly amplified by concurrent administration of metformin.
https://www.prnewswire.com/news-releases/ther...98005.html
3) supercharging those bodies that need a boost w/ StemVacs2 :
The current data suggests that StemVacs™ can activate natural killer cells while at the same time suppressing lung inflammation. This dual mechanism of action makes StemVacs™ a promising candidate for treatment of coronavirus.
"The activation of natural killer cells caused by StemVacs™ was so significant that we were able to obverse inhibition of tumor growth.
https://www.prnewswire.com/news-releases/ther...89133.html
4) repairing and restoring with TSOI cord blood therapy :
The patent application covers new data in which combinations of pterostilbene and other compounds with cord blood are shown to be capable of suppressing lung inflammation associated with COVID-19
https://www.prnewswire.com/news-releases/san-...57622.html
1) prevention with QuadraMune (500 volunteer trial for prevention and protection) ,
https://www.prnewswire.com/news-releases/ther...71981.html
2) QM and Metformin used together :It was discovered that the ability of QuadraMune™ to protect the lungs from inflammation that resembles coronavirus-induced pathology is markedly amplified by concurrent administration of metformin.
https://www.prnewswire.com/news-releases/ther...98005.html
3) supercharging those bodies that need a boost w/ StemVacs2 :
The current data suggests that StemVacs™ can activate natural killer cells while at the same time suppressing lung inflammation. This dual mechanism of action makes StemVacs™ a promising candidate for treatment of coronavirus.
"The activation of natural killer cells caused by StemVacs™ was so significant that we were able to obverse inhibition of tumor growth.
https://www.prnewswire.com/news-releases/ther...89133.html
4) repairing and restoring with TSOI cord blood therapy :
The patent application covers new data in which combinations of pterostilbene and other compounds with cord blood are shown to be capable of suppressing lung inflammation associated with COVID-19
https://www.prnewswire.com/news-releases/san-...57622.html
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)